Search Results - "Ducolone, A."
-
1
Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC)
Published in Annals of oncology (01-01-2005)“…Background: Taxotere® (docetaxel) at the dose of 75 mg/m2 every 3 weeks is a standard therapy for pretreated non-small-cell lung cancer (NSCLC). The aim of…”
Get full text
Journal Article -
2
"Natural History" of Pulmonary Hypertension in a Series of 131 Patients with Chronic Obstructive Lung Disease
Published in American journal of respiratory and critical care medicine (15-07-2001)“…The prognostic value and the evolution of pulmonary hypertension (PH) in patients with markedly hypoxemic chronic obstructive pulmonary disease (COPD), treated…”
Get full text
Journal Article -
3
Randomised, multicentre phase II study assessing two doses of docetaxel (75 or 100 mg/m2) as second-line monotherapy for non-small-cell lung cancer
Published in Annals of oncology (01-01-2004)“…Background: The survival benefit associated with first-line chemotherapy in advanced lung cancer led to the need for second-line chemotherapy. Docetaxel…”
Get full text
Journal Article -
4
Pulmonary hypertension associated with disorders of the respiratory system
Published in La Presse médicale (1983) (05-11-2005)“…Pulmonary hypertension associated with disorders of the respiratory system is defined by a pulmonary artery mean pressure above 20 mmHg at rest in stable…”
Get full text
Journal Article -
5
Physiological functional tests to evaluate pulmonary arterial hypertension
Published in Revue des maladies respiratoires (01-12-2005)“…Pulmonary arterial hypertension (PAH) is a rare and complex disease, which requires careful diagnostic evaluation. Most patients have a mild decrease in lung…”
Get more information
Journal Article -
6
Severe pulmonary hypertension and chronic obstructive pulmonary disease
Published in American journal of respiratory and critical care medicine (15-07-2005)“…Severe pulmonary hypertension occurs occasionally in patients with chronic obstructive pulmonary disease (COPD), but no detailed description of these patients…”
Get full text
Journal Article -
7
Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease
Published in Thorax (01-10-1981)“…In 175 patients with chronic obstructive lung disease (157 chronic bronchitic and 18 emphysematous patients) exhibiting moderate to severe airway obstruction…”
Get full text
Journal Article -
8
A phase II trial of radiochemotherapy with daily carboplatin, after induction chemotherapy (carboplatin and etoposide), in locally advanced nonsmall-cell lung cancer: final analysis
Published in International journal of radiation oncology, biology, physics (01-04-1997)“…To evaluate feasibility and efficacy of concomitant radiochemotherapy (CRCT) in Stage IIIB nonsmall-cell lung cancer (NSCLC), two induction chemotherapy cycles…”
Get more information
Journal Article -
9
Induction or consolidation chemotherapy for unresectable stage III non-small-cell lung cancer patients treated with concurrent chemoradiation: a randomised phase II trial GFPC – IFCT 02-01
Published in European journal of cancer (1990) (01-01-2016)“…Abstract Purpose The objective of this randomised phase II study was to evaluate the impact in terms of response and toxicities of induction or consolidation…”
Get full text
Journal Article -
10
Regulation of Endothelin-1 at Rest and During a Short Steady-State Exercise in 21 COPD Patients
Published in Pulmonary pharmacology & therapeutics (01-04-1998)“…Endothelin-1 (ET-1) is a vasoconstrictive peptide which may play a relevant role in the pathogenesis of pulmonary hypertension (PH) in COPD patients. We…”
Get full text
Journal Article -
11
First line chemotherapy with gemcitabine in advanced non-small cell lung cancer elderly patients: a randomized phase II study of 3-week versus 4-week schedule
Published in Lung cancer (Amsterdam, Netherlands) (01-03-2005)“…This randomized phase II multicenter trial aimed at evaluating the efficacy and safety of the 4-week versus 3-week schedules of gemcitabine monotherapy in…”
Get full text
Journal Article -
12
Conventional radiation (RT) with daily carboplatin (Cb) compared to RT alone after induction chemotherapy (ICT) [vinorelbine (Vr)-cisplatine (P)]: Final results of a randomized phase III trial in stage III unresectable non small cell lung (NSCLC) cancer. Study CRG/BMS/NPC/96 of the French Lung Cancer Study Group FNCLCC and IFCT
Published in Journal of clinical oncology (01-06-2005)“…Abstract only…”
Get full text
Journal Article -
13
-
14
Rôle du reflux gastro-œsophagien dans l'asthme du nourrisson et du jeune enfant
Published in Archives de pédiatrie : organe officiel de la Société française de pédiatrie (01-08-2002)Get full text
Journal Article -
15
Navelbine (NVB)-cisplatin (CDDP) induction chemotherapy (ICT) followed by radiation with or without daily carboplatin (CBDCA) in locally advanced unresectable non small cell lung cancer: Intermediate analysis of a french, multicenter phase III randomized trial
Published in Lung cancer (Amsterdam, Netherlands) (01-09-2000)Get full text
Journal Article -
16
Le cancer bronchique du sujet âgé : Les cancers thoraciques
Published in Oncologie (Paris, France) (2008)Get full text
Journal Article -
17
-
18
Gastroesophageal reflux in patients with asthma and chronic bronchitis
Published in The American review of respiratory disease (01-02-1987)“…To determine the relationship between gastroesophageal (GE) reflux and pulmonary disease, we studied 21 asthmatics, 30 chronic bronchitics, 6 patients with GE…”
Get more information
Journal Article -
19
Tolerance test to an inspiratory resistive load and resistive training of respiratory muscles. Preliminary critical study in kyphoscoliotic patients
Published in Revue de pneumologie clinique (1988)“…Is increased tolerance to an additional inspiratory load after resistive training always due to respiratory muscle endurance? To answer this question, 5…”
Get more information
Journal Article -
20
Is chemotherapy with cisplatin useful in non small cell bronchial cancer at staging IV? Results of a randomized study
Published in Bulletin du cancer (1991)“…The benefit of chemotherapy for patients with disseminated non small cell lung cancer (NSCLC) is controversial. The introduction of cisplatinum in the…”
Get more information
Journal Article